{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:36:46Z","timestamp":1785609406685,"version":"3.56.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"\n Background:<\/jats:title>\n Azathioprine is a first-line drug in treating neuromyelitis optica spectrum disorders (NMOSD). To exhibit its bioactivity, azathioprine needs to be converted to thiopurine nucleotides (TPNs) including 6-thioguanine nucleotides (6-TGNs) and 6-methylmercaptopurine nucleotides (6-MMPNs) that are affected by genetic polymorphisms. This study aims to develop an LC-MS\/MS method for the analysis of erythrocyte concentrations of TPNs and to evaluate their associations with variants of various genes (MTHFR<\/jats:italic>, TPMT<\/jats:italic>, HLA<\/jats:italic>, SLC29A1<\/jats:italic>, SLC28A2<\/jats:italic>, SLC28A3<\/jats:italic>, ABCB1<\/jats:italic>, and ABCC4<\/jats:italic>) in patients with NMOSD.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Erythrocyte 6-TGNs and 6-MMPNs were converted to their free bases 6-thioguanine and 6-methylmercaptopurine derivative by 1-hour acid hydrolysis at 95\u00b0C. An LC-MS\/MS method was developed, validated, and used to study 32 patients with NMOSD to determine these free bases. Genetic variants were identified by MassARRAY (Sequenom) and multiple SNaPshot techniques. The associations between genetic variants and the concentrations of TPNs or the 6-MMPNs:6-TGNs ratio were evaluated by PLINK software using linear regression.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Methanol and water were used for separation with a total run time of 6.5 minutes. The lowest limit of quantification was 0.1 \u03bcmol\/L with an injection volume of 10 \u03bcL. rs10868138 (SLC28A3<\/jats:italic>) was associated with a higher erythrocyte concentration of 6-TGNs (P<\/jats:italic> = 0.031), whereas rs12378361 (SLC28A3<\/jats:italic>) was associated with a lower erythrocyte concentration of 6-TGNs (P<\/jats:italic> = 0.0067). rs507964 (SLC29A1<\/jats:italic>) was significantly associated with a lower erythrocyte concentration of 6-MMPNs (P<\/jats:italic> = 0.024) and a lower 6-MMPNs:6-TGNs ratio (P<\/jats:italic> = 0.029).<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n An LC-MS\/MS method for the analysis of erythrocyte TPNs was developed, validated, and used to study 32 patients with NMOSD. SLC29A1<\/jats:italic> and SLC28A3<\/jats:italic> were associated with the erythrocyte concentrations of TPNs and 6-MMPNs:6-TGNs ratio. Further studies are needed to confirm these results.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000362","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T17:04:00Z","timestamp":1481216640000},"page":"5-12","source":"Crossref","is-referenced-by-count":11,"title":["LC-MS\/MS Analysis of Erythrocyte Thiopurine Nucleotides and Their Association With Genetic Variants in Patients With Neuromyelitis Optica Spectrum Disorders Taking Azathioprine"],"prefix":"10.1097","volume":"39","author":[{"given":"Shenghui","family":"Mei","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University;"},{"name":"Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Li","sequence":"additional","affiliation":[{"name":"Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Gong","sequence":"additional","affiliation":[{"name":"Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University;"},{"name":"Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University;"},{"name":"Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[{"name":"Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zhou","sequence":"additional","affiliation":[{"name":"Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leting","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University;"},{"name":"Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/FPC.0b013e328334338f","article-title":"Thiopurine pathway","volume":"20","author":"Zaza","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.2649979","article-title":"The purine path to chemotherapy","volume":"244","author":"Elion","year":"1989","journal-title":"Science"},{"key":"R4-20230814","first-page":"1670","article-title":"Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy","volume":"55","author":"Warren","year":"1995","journal-title":"Cancer Res."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bcp.12365","article-title":"Thiopurine monitoring in children with inflammatory bowel disease: a systematic review","volume":"78","author":"Konidari","year":"2014","journal-title":"Br J Clin Pharmacol."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.MIB.0000439068.71126.00","article-title":"Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis","volume":"20","author":"Moreau","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clpt.2003.12.001","article-title":"Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity","volume":"75","author":"Nygaard","year":"2004","journal-title":"Clin Pharmacol Ther."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/FTD.0b013e318283ed5d","article-title":"Improved method for therapeutic drug monitoring of 6-thioguanine nucleotides and 6-methylmercaptopurine in whole-blood by LC\/MSMS using isotope-labeled internal standards","volume":"35","author":"Kirchherr","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1373\/clinchem.2005.050831","article-title":"Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine\/6-mercaptopurine therapy","volume":"51","author":"Dervieux","year":"2005","journal-title":"Clin Chem."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinbiochem.2004.05.025","article-title":"Improved HPLC methodology for monitoring thiopurine metabolites in patients on thiopurine therapy","volume":"37","author":"Stefan","year":"2004","journal-title":"Clin Biochem."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2003.08.006","article-title":"High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood","volume":"796","author":"Erb","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample","volume":"583","author":"Lennard","year":"1992","journal-title":"J Chromatogr."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/clinchem\/48.1.61","article-title":"HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy","volume":"48","author":"Dervieux","year":"2002","journal-title":"Clin Chem."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/clinchem\/44.12.2511","article-title":"Identification of 6-methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/ac2031699","article-title":"Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry","volume":"84","author":"Hofmann","year":"2012","journal-title":"Anal Chem."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/MIB.0000000000000347","article-title":"Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine","volume":"21","author":"Lee","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3109\/00365521003642559","article-title":"Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration","volume":"45","author":"Kochi","year":"2010","journal-title":"Scand J Gastroenterol."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00054725-200307000-00004","article-title":"Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine","volume":"9","author":"Thomas","year":"2003","journal-title":"Inflamm Bowel Dis."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ecco-jcc\/jjv084","article-title":"Body mass index and smoking affect thioguanine nucleotide levels in inflammatory bowel disease","volume":"9","author":"Poon","year":"2015","journal-title":"J Crohns Colitis."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1373\/49.2.260","article-title":"Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods","volume":"49","author":"Shipkova","year":"2003","journal-title":"Clin Chem."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1097\/MIB.0000000000000570","article-title":"Impact of genetic polymorphisms on 6-thioguanine nucleotide levels and toxicity in pediatric patients with IBD treated with azathioprine","volume":"21","author":"Lee","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood-2005-01-0143","article-title":"Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment","volume":"106","author":"Zaza","year":"2005","journal-title":"Blood"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/pgs.13.226","article-title":"Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes","volume":"15","author":"Matimba","year":"2014","journal-title":"Pharmacogenomics"},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/PGS.15.62","article-title":"Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients","volume":"16","author":"Hareedy","year":"2015","journal-title":"Pharmacogenomics"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2006.02.134","article-title":"Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines","volume":"343","author":"Fotoohi","year":"2006","journal-title":"Biochem Biophys Res Commun."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/tpj.2014.47","article-title":"Testing for thiopurine methyltransferase status for safe and effective thiopurine administration: a systematic review of clinical guidance documents","volume":"14","author":"Burnett","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3949\/ccjm.82a.14106","article-title":"Should thiopurine methyltransferase (TPMT) activity be determined before prescribing azathioprine, mercaptopurine, or thioguanine?","volume":"82","author":"DiPiero","year":"2015","journal-title":"Cleve Clin J Med."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.curtheres.2006.07.002","article-title":"Correlation of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentration in Han Chinese patients treated with azathioprine 25 to 100 mg: a 1-year, single-center, prospective study","volume":"67","author":"Zhang","year":"2006","journal-title":"Curr Ther Res Clin Exp."},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2710.2007.00858.x","article-title":"Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?","volume":"32","author":"Fakhoury","year":"2007","journal-title":"J Clin Pharm Ther."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2217\/pgs.14.32","article-title":"Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring","volume":"15","author":"Chouchana","year":"2014","journal-title":"Pharmacogenomics"},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2036.2012.05084.x","article-title":"High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment","volume":"35","author":"van Egmond","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"Young","year":"2013","journal-title":"Mol Aspects Med."},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.leukres.2007.09.015","article-title":"Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine","volume":"32","author":"Peng","year":"2008","journal-title":"Leuk Res."},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1124\/dmd.110.035220","article-title":"Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity","volume":"38","author":"Li","year":"2010","journal-title":"Drug Metab Dispos."},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1389200043489162","article-title":"Mammalian nucleoside transporters","volume":"5","author":"Kong","year":"2004","journal-title":"Curr Drug Metab."},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nm0197-89","article-title":"Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs","volume":"3","author":"Griffiths","year":"1997","journal-title":"Nat Med."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/0008-5472.CAN-03-3884","article-title":"Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance","volume":"64","author":"Huang","year":"2004","journal-title":"Cancer Res."},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1073\/pnas.98.2.581","article-title":"High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"98","author":"Buetow","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem."},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4347(00)00513-2","article-title":"Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood","volume":"757","author":"Pike","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl."},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jchromb.2010.03.004","article-title":"Limited stability of thiopurine metabolites in blood samples: relevant in research and clinical practise","volume":"878","author":"de Graaf","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","article-title":"The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations","volume":"9","author":"Collie-Duguid","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0009-9236(98)90021-2","article-title":"Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans","volume":"64","author":"Loennechen","year":"1998","journal-title":"Clin Pharmacol Ther."},{"key":"R48-20230814","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/dmd.105.006270","article-title":"Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2","volume":"34","author":"Owen","year":"2006","journal-title":"Drug Metab Dispos."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201702000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:01:08Z","timestamp":1692050468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201702000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000362","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}